|
|
 |
|
 |
June 09, 2006
MDX AGM Summary MDX to Change Company Name to Urodynamix Technologies Ltd. and Trading Symbol to URO
Vancouver, BC - (June 8, 2006) MDX Medical Inc. (TSX.V: MDX) conducted it's AGM on June 7, 2006 and all matters outlined in the Notice of Meeting and Information Circular were passed.
Items passed included; acceptance of the consolidated financial statements for the year end December 31, 2005, fixing the number of directors for the ensuing year at four, re-electing the four existing directors, re-appointment of Berris Mangan, Chartered Accountants as auditor, approval of the company's stock option plan and approval of the change in company name to Urodynamix Technologies Ltd.
The company name change will be effective June 21, 2006. At the same time the company's trading symbol on the TSX-Venture will become URO. The Company web site will also be changed to www.urodynamix.com
The new company name reflects the company's focus on urology, bladder diagnostics and monitoring solutions. The Company's products are designed for urologists, gynecologists, and primary care physicians who diagnose and treat conditions relating to the urinary tract, bladder and reproductive systems. These physicians are the primary care providers for sufferers of urinary incontinence, a condition that affects over 200 million people worldwide.
The new name, Urodynamix, is also based on urodynamics, which are a series of tests conducted on patients suffering from urinary incontinence to diagnose the condition. The current tests are invasive, painful, time consuming and require expensive equipment and consumables. Urodynamix is currently commercializing new painless and non-invasive technology to replace this current test. In addition, Urodynamix is developing its NIRS technology for other applications and clinical conditions.
Barry Allen, President and Chief Executive Officer, said,"Our new name, Urodynamix, reflects the company's focus on the attractive and growing markets in the areas of urodynamics, prostate screening and other applications of the technology relating to urology."
On behalf of the Board,
"Barry Allen"
President & CEO
MDX Medical Inc.
Certain information contained in this press release may be forward looking and is subject to unknown risks, which could cause actual results to differ materially from those, set forth or implied herein. Although the Company believes that the expectations reflected in such forward looking statements are reasonable, it can give no assurance that such expectations will prove correct.
The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
For further information, please contact:
Barry Allen
Email: ballen@urodynamix.com |
|  |
|
